PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1986 | 1 |
| 1987 | 1 |
| 1991 | 1 |
| 1993 | 1 |
| 1994 | 1 |
| 1996 | 1 |
| 1998 | 1 |
| 1999 | 5 |
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 10 |
| 2007 | 7 |
| 2008 | 37 |
| 2009 | 49 |
| 2010 | 52 |
| 2011 | 48 |
| 2012 | 52 |
| 2013 | 71 |
| 2014 | 63 |
| 2015 | 60 |
| 2016 | 48 |
| 2017 | 54 |
| 2018 | 39 |
| 2019 | 55 |
| 2020 | 36 |
| 2021 | 58 |
| 2022 | 73 |
| 2023 | 45 |
| 2024 | 79 |
| 2025 | 61 |
| 2026 | 79 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Immunol Rev"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Oxidative Stress, Post-Translational Modifications, and Type 1 Diabetes Pathogenesis.
- Winstead CJ, Hodel M, Tse HM.
- Immunol Rev. 2026 Oct;343(1):e70182. doi: 10.1111/imr.70182.
- PMCID: PMC13669990
Winstead CJ, et al.Immunol Rev. 2026.PMCID: PMC13669990 -
Entering the Age of Specificity in T Cell Immunity.
- Thomas PG.
- Immunol Rev. 2026 Oct;343(1):e70184. doi: 10.1111/imr.70184.
- PMCID: PMC13643677
Thomas PG.Immunol Rev. 2026.PMCID: PMC13643677 -
Beta Cell Stress to Epitope Diversification: Post-Translationally Modified Antigens in Type 1 Diabetes.
- Proffer ML, Roy S, Piganelli JD.
- Immunol Rev. 2026 Oct;343(1):e70183. doi: 10.1111/imr.70183.
- PMCID: PMC13643625
Proffer ML, et al.Immunol Rev. 2026.PMCID: PMC13643625 -
Sex Differences in Alloimmunity and Other Immunological Considerations in Organ Transplantation.
- Perry WA, Sen P.
- Immunol Rev. Author manuscript. 2026 Mar;338(1):e70104. doi: 10.1111/imr.70104.
- PMCID: PMC13644580
Perry WA, et al.Immunol Rev. Author manuscript. 2026.PMCID: PMC13644580 -
Discovery of Post-Translationally Modified Epitopes in Autoimmunity: Someone Has to Fish so Everyone Can Eat.
- Arshad S, Cameron BM, Joglekar AV.
- Immunol Rev. 2026 Oct;343(1):e70179. doi: 10.1111/imr.70179.
- PMCID: PMC13617164
Arshad S, et al.Immunol Rev. 2026.PMCID: PMC13617164 -
BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity.
- Luff DH, Schweighoffer E, Tybulewicz VLJ.
- Immunol Rev. 2026 Sep;342(1):e70170. doi: 10.1111/imr.70170.
- PMCID: PMC13586541
Luff DH, et al.Immunol Rev. 2026.PMCID: PMC13586541 -
Complement Activation by Post-Translationally Modified Proteins: Links to Chronic Inflammation and Autoimmunity.
- van Greevenbroek MMJ, Trouw LA.
- Immunol Rev. 2026 Sep;342(1):e70166. doi: 10.1111/imr.70166.
- PMCID: PMC13580110
van Greevenbroek MMJ, et al.Immunol Rev. 2026.PMCID: PMC13580110 -
Autoantibodies and T Cells Target Citrullinated and Homocitrullinated Antigens in Rheumatoid Arthritis.
- James EA, Callebaut A, Buckner JH, Kwok WW.
- Immunol Rev. 2026 Sep;342(1):e70178. doi: 10.1111/imr.70178.
- PMCID: PMC13575444
James EA, et al.Immunol Rev. 2026.PMCID: PMC13575444 -
Defining Functional T Cell Receptor Repertoires With Nanovial-Based Screening.
- Di Carlo D.
- Immunol Rev. 2026 Sep;342(1):e70171. doi: 10.1111/imr.70171.
- PMCID: PMC13558779
Di Carlo D.Immunol Rev. 2026.PMCID: PMC13558779 -
T Cell Thoughts.
- Chudakov DM.
- Immunol Rev. 2026 Sep;342(1):e70172. doi: 10.1111/imr.70172.
- PMCID: PMC13554830
Chudakov DM.Immunol Rev. 2026.PMCID: PMC13554830